Summary
When bare-metal stents are used, diabetic patients with coronary artery disease have a poorer prognosis than non-diabetic patients after coronary interventions. In clinical studies, it could be demonstrated that the disadvantage for diabetic patients is not present when drug-eluting stents are used. Today, two types of drug-eluting stents are clinically used: the sirolimus-eluting stent (Cypher™) and the paclitaxel-eluting stent (Taxus™). Even the high risk group of patients with in-stent stenosis can be efficiently treated with drugeluting stents.
Zusammenfassung
Koronarkranke Diabetiker haben grundsätzlich eine schlechtere Prognose als Nichtdiabetiker nach perkutanen Koronarinterventionen, wenn nichtbeschichtete Koronarstents verwendet werden. In klinischen Studien konnte gezeigt werden, dass bei Verwendung von so genannten Medikamenten eluierenden Stents dieser Nachteil für Diabetiker nicht mehr besteht. Zurzeit sind 2 Typen von Medikamenten eluierenden Stents untersucht. Es handelt sich um einen Sirolimus eluierenden Stent (Cypher™) sowie einen Paclitaxel eluierenden Stent (Taxus™™). Selbst in der Hochrisikogruppe der Instentrezidivpatienten mit Diabetes ist die Therapie mit Medikamenten eluierenden Stents effizient und einer Bypassoperation vorzuziehen.
Similar content being viewed by others
References
Abizaid A et al (2001) Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) Trial. Circulation 104:533–538
Brener SJ (2004) Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. Circulation 109:2290–2295
Hannan EL et al (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352:2174-2183
Moussa I et al (2004) Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) Substudy. Circulation 109:2273–2278
Nick EJ et al (2004) Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 109:867–873
Stone GW et al (2004) The TAXUS-IV investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231
The Bypass Angioplasty Revascularization Investigation (BARI) (1996) Investigators comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335:217–225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Motz, W., Kaiser, R. Stenttherapie bei diabeteskranken Koronarpatienten. Clin Res Cardiol 95 (Suppl 1), i27–i30 (2006). https://doi.org/10.1007/s00392-006-1111-2
Issue Date:
DOI: https://doi.org/10.1007/s00392-006-1111-2